Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Neuroblastoma 4Central Nervous System Neoplasms 3Small Cell Lung Carcinoma 2Sarcoma 2Ovarian Neoplasms 2Neoplasms, Germ Cell and Embryonal 2Multiple Myeloma 2Lung Neoplasms 2Leukemia 2Hodgkin Disease 2Brain Neoplasms 2Teratoma 1Seminoma 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Germ Cell Cancer 1Nonseminomatous germ cell tumor 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms, Unknown Primary 1Neoplasms 1Nasopharyngeal Neoplasms 1Malignant mesenchymal tumor 1Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell 1Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1

Interventions

Radiotherapy 7Ifosfamide 6Vincristine 5Filgrastim 5Doxorubicin 5Dactinomycin 5Cyclophosphamide 5Etoposide 3sargramostim 2Topotecan 2Granulocyte Colony-Stimulating Factor 2Chemotherapy, Adjuvant 2Carboplatin 2trioctyl phosphine oxide 1indolepropanol phosphate 1etoposide phosphate 1Watchful Waiting 1Vinorelbine 1Radiotherapy, Conformal 1Radiation 1Observation 1Neoadjuvant Therapy 1Irinotecan 1Granulocyte-Macrophage Colony-Stimulating Factor 1Epirubicin 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Malignant mesenchymal tumor × etoposide phosphate × Clear all
NCT00354744 2020-01-29

High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma

Children's Oncology Group

Phase 3 Completed
109 enrolled 12 charts
Sarcoma

Malignant mesenchymal tumor, Rhabdomyosarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡